Actuate Therapeutics, Inc. (ACTU)’s Elraglusib Elraglusib Trial Hits Key Goals in Pancreatic Cancer
Actuate Therapeutics, Inc.
Actuate Therapeutics Inc. (ACTU)
Market is closed
Sector: Healthcare
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Voss Capital Travis Cocke | 1,725,000 | $2,639,250 | 0.12% | |
| 2. | AQR Capital Management Cliff Asness | 127,493 | $195,064 | +371% | 0% |
| 3. | Millennium Management Israel Englander | 96,684 | $147,927 | 0% | |
| 4. | Connective Capital Management Rob Romero | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| Not reported | 140,844 | USD value unavailable | 442,560 | 2026-10-28 | Filing | |
| $7.00 | 71,428 | $499,996.00 | 196,428 | 2025-06-27 | Filing | |
| $7.00 | 71,428 | $499,996.00 | 196,428 | 2025-06-27 | Filing | |
| $7.00 | 71,428 | $499,996.00 | 196,428 | 2025-06-27 | Filing | |
| $8.00 | 125,000 | $1,000,000.00 | 125,000 | 2024-08-14 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $5.80 | 280,000 | $1,624,000.00 | 904,795 | 2026-01-05 | Filing | |
| $8.00 | 2,324 | $18,592.00 | 131,248 | 2024-08-14 | Filing | |
| $8.00 | 17,361 | $138,888.00 | 980,433 | 2024-08-14 | Filing | |
| $8.00 | 5,314 | $42,512.00 | 300,143 | 2024-08-14 | Filing | |
| $8.00 | 2,324 | $18,592.00 | 131,248 | 2024-08-14 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 104,315 | $81,333 | 0% | |
| 2. | 19,028 | $14,836 | 0% | |
| 3. | 11,915 | $9,290 | 0% | |
| 4. | 10,973 | $8,555 | 0% | |
| 5. | 10,000 | $7,797 | 0% |
News See All
Hedge Fund Resource Center